HHS Leaves Door Open to Future Medicare Coverage of Obesity Drugs

Last week, The Trump administration reversed a Biden-era proposal for Medicare coverage of anti-obesity treatments. But on Monday, HHS suggested it is open to future policy considerations toward this end.

Scroll to Top